Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

446 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Review of Metformin Use for Type 2 Diabetes Prevention.
Moin T, Schmittdiel JA, Flory JH, Yeh J, Karter AJ, Kruge LE, Schillinger D, Mangione CM, Herman WH, Walker EA. Moin T, et al. Among authors: walker ea. Am J Prev Med. 2018 Oct;55(4):565-574. doi: 10.1016/j.amepre.2018.04.038. Epub 2018 Aug 17. Am J Prev Med. 2018. PMID: 30126667 Free PMC article. Review.
Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program.
Knowler WC, Hamman RF, Edelstein SL, Barrett-Connor E, Ehrmann DA, Walker EA, Fowler SE, Nathan DM, Kahn SE; Diabetes Prevention Program Research Group. Knowler WC, et al. Among authors: walker ea. Diabetes. 2005 Apr;54(4):1150-6. doi: 10.2337/diabetes.54.4.1150. Diabetes. 2005. PMID: 15793255 Free PMC article. Clinical Trial.
Menopause and risk of diabetes in the Diabetes Prevention Program.
Kim C, Edelstein SL, Crandall JP, Dabelea D, Kitabchi AE, Hamman RF, Montez MG, Perreault L, Foulkes MA, Barrett-Connor E; Diabetes Prevention Program Research Group. Kim C, et al. Menopause. 2011 Aug;18(8):857-68. doi: 10.1097/gme.0b013e31820f62d0. Menopause. 2011. PMID: 21709591 Free PMC article. Clinical Trial.
Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program.
Delahanty LM, Pan Q, Jablonski KA, Watson KE, McCaffery JM, Shuldiner A, Kahn SE, Knowler WC, Florez JC, Franks PW; Diabetes Prevention Program Research Group. Delahanty LM, et al. Diabetes Care. 2012 Feb;35(2):363-6. doi: 10.2337/dc11-1328. Epub 2011 Dec 16. Diabetes Care. 2012. PMID: 22179955 Free PMC article. Clinical Trial.
Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study.
Diabetes Prevention Program Outcomes Study Research Group; Orchard TJ, Temprosa M, Barrett-Connor E, Fowler SE, Goldberg RB, Mather KJ, Marcovina SM, Montez M, Ratner RE, Saudek CD, Sherif H, Watson KE. Diabetes Prevention Program Outcomes Study Research Group, et al. Diabet Med. 2013 Jan;30(1):46-55. doi: 10.1111/j.1464-5491.2012.03750.x. Diabet Med. 2013. PMID: 22812594 Free PMC article. Clinical Trial.
Genetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention Program.
Pollin TI, Isakova T, Jablonski KA, de Bakker PI, Taylor A, McAteer J, Pan Q, Horton ES, Delahanty LM, Altshuler D, Shuldiner AR, Goldberg RB, Florez JC, Franks PW; Diabetes Prevention Program Research Group. Pollin TI, et al. PLoS Genet. 2012;8(8):e1002895. doi: 10.1371/journal.pgen.1002895. Epub 2012 Aug 30. PLoS Genet. 2012. PMID: 22951888 Free PMC article.
Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program.
Florez JC, Jablonski KA, McAteer JB, Franks PW, Mason CC, Mather K, Horton E, Goldberg R, Dabelea D, Kahn SE, Arakaki RF, Shuldiner AR, Knowler WC; Diabetes Prevention Program Research Group. Florez JC, et al. PLoS One. 2012;7(9):e44424. doi: 10.1371/journal.pone.0044424. Epub 2012 Sep 11. PLoS One. 2012. PMID: 22984506 Free PMC article. Clinical Trial.
446 results